Liver disease is usually a profound life-changing disease as the liver functions affects almost every other organ system in the body. In the present study the hepatoprotective effect of curcumin, diclofenac sodium alone or in combination against liver injury with CCl4 and ischemia/reperfusion (I/R) model was studied. METHODS: The effect of curcumin and diclofenac sodium in doses of 200 mg/kg body weight (bw) and 5 mg/kg bw respectively against liver toxicity induced by CCl4 (1ml/kg bw) in olive oil [1:1 (v/v)] every other day for 8 weeks and by hepatic ischemia/reperfusion in adult male albino rats was studied. Different antioxidant and liver function parameters as well as histopathological findings were reported to find the protective effect of both curcumin and diclofenac sodium against hepatotoxicity. Statistical analysis was carried out by using one way ANOVA followed by Student Newman Keuls multiple comparisons test. RESULT: It was showed that curcumin protected against CCl4-induced hepatotoxicity as well as ischemia/reperfusion induced liver injury. On the other hand, diclofenac sodium caused deleterious effects especially in presence of CCl4 where high mortality rate was observed. In addition, administration of curcumin and diclofenac sodium concurrently with CCl4 did not show any significant improvement in animals. CONCLUSION: The hepatoprotective effect of curcumin is due to its antioxidant potential. Diclofenac sodium markedly synergized the hepatotoxic effect of CCl4. Curcumin could be used safely to protect the liver against various insults. Further clinical trials are needed to prove this claim.
INTRODUCTION
Curcumin is the principal curcuminoid, which is a member of the ginger family (Zingiberaceae). The other two curcuminoids are desmethoxycurcumin and bis-desmethoxycurcumin. Natural food colourant obtained in a pure form. Extracted from turmeric root is used as a spice, food preservative and colouring material in India, China and South East Asia [1] . For the last few decades, extensive work has been done to establish the biological activities and pharmacological actions of turmeric and its extracts [2] .
Diclofenac Sodium is a non-steroidal antiinflammatory drug. The anti-inflammatory activity of diclofenac sodium is primarily attributed to inhibition of distinct steps in the arachidonic acid cascade, particularly, the cyclo-oxygenase and lipoxygenase pathways this leads to a sharp reduction in the formation of prostaglandin, prostacyclin, and thromboxane products, all key mediators of inflammation. Recent work discloses that at higher concentrations. Diclofenac sodium also reduces the formation of products of the lipoxygenase pathway (5-hydroxyeicosatetraenoic acid, leukotrienes). The mechanism by which this evolves, however, appears to be unrelated to direct inhibition of lipoxygenase. Instead, by enhancing its reincorporation into triglycerides, diclofenac sodium reduces the intracellular level of free arachidonic acid [3] .
In the present study the effect of curcumin, diclofenac sodium alone or in combination against liver injury with ccl4 and I/R model was studied.
MATERIALS AND METHODS

Animals
In the present investigation, one hundred adult male albino rats, weighing 150-200 g, were used. Animals were obtained from the National Research center, Giza, Egypt. Animals were fed on commercial standard pellets enriched with barley and carrots and tap water was supplied ad-libitum
The experiments were carried out according to the National Regulations on Animal Welfare and Institutional Animal Ethical Committee (IAEC). 
Drugs
Hepatic Ischemia/Reperfusion (IR) Injury insults
Hepatic IR was performed according to the method described by Colletti et al. [5] . Rats were fasted for 12 hours before the operation, intraperitoneally anaesthesized with thiopental sodium (10 mg/kg) [6] and underwent midline laparotomy.
Animal Grouping: Drugs were given to rats as oral daily doses for 7 consecutive days. Rats were subjected to 30 minutes of ischemia followed by 30 minutes of reperfusion.
Rats were divided into 6 groups each group consists of 10 rats according to the following protocol:
Group 1: Sham-operated control (1ml/kg saline).
Group 2: IR control (1ml/kg saline). Group 3: Received diclofenac sodium (5 mg/kg) followed by IR.
Group 4: Received curcumin extract (200 mg/kg) followed by IR.
Blood Sampling
Blood samples (3ml) were collected from the retro-orbital plexus of each rat into dry centrifuge tubes and left to clot at room temperature. Serum samples were obtained after centrifugation at 1500 rpm for 10 min, then kept in clean epindorf tubes at 20°C until analysis.
The separated sera were used for the estimation of serum activities of ALT, AST, ALP and total bilirubin.
Tissue sampling
From each animal one part from the liver tissues was taken and added to 4 parts of the ice cold normal saline (0.9%) used for the antioxidant studies.
Determination of liver function tests
Aminotransferases activity (ALT and AST) was determined according to [7] . Alkaline phosphatase activity (ALP) activity was determined in serum samples according to [8] . Total bilirubin study according to the method described by Jendrassik and Grof (1938) [9] . Lactate dehydrogenase activity was measured according to the modified method [10] .
Determination of Antioxidant studies
The reduced glutathione GSH content in liver and kidney homogenates (20%) was determined by the colorimetric method [11] and modified by [12] . The lipid peroxides content in the liver and kidney homogenates (20%) was determined by the colorimetric method [13] . Catalase activity was measured in liver homogenate according to [14] .
Statistical methods
Statistical analysis was carried out by using one way ANOVA followed by Student Newman Keuls multiple comparisons test and SPSS version (9.0). Data were represented as mean±SE at p ≤ 0.05 [15] .
RESULTS
Effect of diclofenac sodium and curcumin on CCl 4 induced hepatotoxicity
Effect on liver function tests The mean normal control values of serum ALT, AST, ALP and bilirubin levels were 58.64±5.4, 75.62±3.58, 165.56±10.94 U/l and 0.45±0.07 mg/dl respectively.
CCl 4 significantly increased serum ALT, AST, ALP and bilirubin levels to about 300%, 194%, 267% and 383% respectively, compared to the respective control values.
Treatment of rats with diclofenac sodium concurrently with CCl 4 for 8 weeks caused severe toxicity leading to 100% mortality. Treatment of rats with curcumin concurrently with CCl 4 for 8 weeks significantly decreased serum ALT, AST, ALP and bilirubin levels to about 55%, 66%, 66% and 56% respectively, compared to CCl 4 treated rats. On the other hand administration of curcumin and diclofenac sodium concurrently with CCl 4 did not show any significant improvement regarding liver function tests and all coming parameters compared to CCl 4 control rats. The results are given in Table 1 . Results in present and coming tables expressed as mean± SE. Statistical analysis was performed using one-way ANOVA test followed by Student-Newman-Keuls multiple comparions test. *Significant p ≤ 0.05 compared to control.; a compared to normal control, b compared to CCl4 group (control +ve). a; compared to normal control, b compared to IR group (control +ve).
Table (5):
Effect of one week oral daily dose administration of diclofenac sodium, curcumin on liver malondialdehyde (MDA) and reduced glutathione (GSH) contents after hepatic ischemia/reperfusion (IR) in rats. (mean ±SE, n=10). 
Groups ALT (I /U) AST (I /U)
Effect on liver lactate dehydrogenase (LDH) activity and malondialdehyde (MDA) content
The mean normal control values of liver LDH activity and MDA content were 561.31±87.62 U/l and 31.49±3.93 nmol/ml respectively.
Treatment with CCl 4 for 8 weeks significantly increased liver LDH activity and MDA content to about 221% and 306% respectively compared to the respective control values. Treatment of rats with curcumin concurrently with CCl 4 for 8 weeks significantly decreased liver LDH activity and MDA content to about 62% and 58% respectively, compared to CCl 4 control rats. The results are given in Table 2 .
Effect on liver reduced glutathione (GSH) content and catalase (CAT) activity
The mean normal control values of liver GSH content and CAT activity were 17.78±0.73 and 0.58±0.06 U /g respectively.
Treatment with CCl 4 for 8 weeks significantly decreased liver GSH content and CAT activity to about 28% and 12% respectively, compared to the respective control values. Treatment of rats with curcumin concurrently with CCl 4 for 8 weeks significantly increased liver GSH content and CAT activity to about 215% and 2350% respectively, compared to CCl 4 control rats. The results are given in Table 3 .
Effect of Diclofenac sodium and Curcumin Hepatic Ischemia/Reperfusion (IR) induced hepatotoxicity
Effect on serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities
The mean values of serum ALT and AST levels of sham operated control were 21.79±4.37 and 63.38±8.60 (U/I) respectively. Induction of 30 minutes of hepatic ischemia followed by 30 minutes of reperfusion significantly increased ALT and AST level to about 437% and 192% respectively compared to sham-operated control. Pre-treatment of curcumin significantly decreased the elevated serum ALT and AST level, reaching about 51% and 60% respectively compared to IR control rats. Pretreatment of diclofenac sodium followed by IR increased ALT and AST level to about 418% and 182% respectively compared to sham-operated control. The results are given in Table 4 .
Effect on liver malondialdehyde (MDA) and reduced glutathione (GSH) contents
The mean values of liver MDA and GSH contents of sham operated control were 37.98±9.47 and 16.96±0.72 respectively. Induction of 30 minutes of hepatic ischemia followed by 30 minutes of reperfusion significantly increased liver MDA content to about 352% compared to sham-operated control. Pre-treatment of curcumin significantly decreased the elevated liver MDA content, reaching about 45% compared to IR control rats. Pretreatment of diclofenac sodium followed by IR increased liver MDA content to about 242% compared to sham-operated control. Hepatic IR injury significantly decreased liver GSH content to about 22% compared to sham-operated rats. Pretreatment of curcumin increased liver GSH content, reaching about 297% compared to IR control rats. Pre-treatment of diclofenac sodium followed by IR decreased liver GSH content to about 24% compared to sham-operated control. The results are given in table (5) .
DISCUSSION
In the present study, two main sets of experiments were performed; CCl 4 induced hepatotoxicity and Liver ischemia/reperfusion (IR) insults.
The obtained results revealed that curcumin extract exerted hepatoprotective potential evidenced by decreased serum ALT and AST, ALP and bilirubin levels in addition to restoration of normal hepatic architecture in the histopathological examination. Also decreased LDH and thiobarbituric acid reactive substances content, measured as malondialdehyde; and lead to elevation of both reduced glutathione content and catalase activity.
Similar results were previously reported [16] . Where curcumin protected the liver against CCl 4 and ischemia/reperfusion-induced injury and suppressed hepatic fibrogenesis.
Curcumin possesses several functional groups that exhibit antioxidant activity [17] . The antioxidant effect of curcumin, as seen in the present work is the key protective mechanism of the test agent through the replenishment of hepatocellular GSH content. After cellular uptake, the availability of which is the rate-limiting factor in GSH biosynthesis. This is particularly of value since both IR-induced liver injury [16] .
In the present work, diclofenac sodium was found to causes potentially sever liver injury in rats leads to 100% mortality to the animals as seen in the present study.
The mechanism of diclofenac sodium hepatotoxicity involves covalent protein modification by reactive metabolites [18] , oxidative stress generation by peroxidase-catalyzed reaction [19] , and mitochondrial injury propagation by reactive oxygen species [20] . Diclofenac sodium induced hepatic toxicity was prevented by antioxidants and also cytochrome P450 inhibitors.
Many findings also indicate that declofenac metabolites are capable of causing apoptosis of hepatocytes [20] . This was identified to be related to the ability of the drug to cause oxidative stress that is followed by mitochondrial permeability transition (MPT) [20] .
CONCLUSION
Results obtained in this study demonstrated that use of diclofenac sodium has induced lipid peroxidation and impaired antioxidant defence in mice.
Diclofenac sodium, curcumin and CCl 4 combination significantly increased serum level of ALT, AST, ALP, LDH and total bilirubin. Also markedly increased thiobarbituric acid reactive substances content, measured as malondialdehyde, further more decreased reduced glutathione content and catalase activity. In addition they improved the survival of animals but their hepatoprotective effects were nullified.
It could be concluded that curcumin protected against CCl 4 -induced hepatotoxicity and ischemia/reperfusion induced liver injury. On the other hand diclofenac sodium caused deleterious effects especially in presence of CCl 4 where complete death of the animals was observed. Further clinical studies are needed to prove the previously obtained results.
